dual agonist tirzepatide Unveiling Tirzepatide's Therapeutic Spectrum: A GIP/GLP-1 Targeting Metabolic, Neurological, and Cardiovascular Health changer for advanced Novel Dual Incretin Receptor Agonists

In a November 2024 article featured in The New England Journal of Medicine, researchers found that tirzepatide reduced the risk of cardiovascular death or worsening heart failure in patients with heart failure with preserved ejection fraction and obesity

Research shows that CBT-E helps reduce bingeing

Josh is someone I knew growing up that my sister and I went to school with, so reconnecting with him was truly a blessing

Brand-name Wegovy lists near $1,349/month at retail, Eli Lillys direct Zepbound program starts around $299 for the lowest dose, and a growing list of telehealth platforms advertise compounded semaglutide between $149 and $249 per month

This can be done by using sunscreen every day, with mineral-based sunscreens often being a good choice

Researchers from Mental Health Center Copenhagen in Denmark examined 108 adults with both obesity and alcohol use disorder who were actively trying to cut back on their drinking